Loading...
Ziltivekimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IL6, Ziltivekimab is a proprietary anti-interleukin-6 ligand monoclonal antibody (anti-IL6 mAb), targeting residual inflammatory cardiovascular risk in patients living with advanced chronic kidney disease (CKD).
Biosimilars
Human
Monoclonal
Human
IL6
Human
IgG1 Kappa
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más